Greenberg Roy K, Lytle Bruce
Department of Vascular Surgery, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA.
Circulation. 2008 Apr 29;117(17):2288-96. doi: 10.1161/CIRCULATIONAHA.107.716134.
Morbidity and mortality after conventional repair of thoracoabdominal aneurysms remain high. Alternative techniques have been proposed and are the subject of this report.
Endovascular grafts that have a means of incorporating the visceral vessels into the aortic repair were divided into devices with fenestrations and those with formal branches. Hybrid procedures whereby an extra-anatomic bypass procedure is used to provide inflow to the renal and mesenteric arteries followed by aortic relining with stent grafts were reviewed and tabulated. A description of the techniques and review of the current results are provided. Only 4 series with >10 cases of hybrid procedures have been published. The experience with such a procedure suggests feasibility, but most reports describe a persistently high risk of mortality (up to 25%). Larger series of fenestrated stent grafts to treat juxtarenal aneurysms have been published, and intermediate-term results confirm the safety and efficacy of the procedure. A larger multicenter trial is under way. Other pure endovascular methods have been used to treat thoracoabdominal aneurysms with both reinforced fenestrations and directional branches. Without counting small series (<10 cases), 2 series exist with approximately 100 cases that noted perioperative mortality rates between 3% and 6%, without evidence of late ruptures.
Endovascular repair of thoracoabdominal aneurysms is feasible and is associated with relatively low perioperative mortality. Several methods of visceral vessel incorporation have been described. Because of persistently high mortality, hybrid procedures will likely be relegated to nonsurgical and nonendovascular patients with sizable aneurysms. Endografts with branches continue to evolve and will be assessed in the context of clinical trials.
胸腹主动脉瘤传统修复术后的发病率和死亡率仍然很高。已提出替代技术,本报告将对此进行探讨。
将能够将内脏血管纳入主动脉修复的血管内移植物分为开窗型和带分支型。回顾并列表展示了杂交手术,即采用解剖外旁路手术为肾动脉和肠系膜动脉提供血流,随后用支架型人工血管进行主动脉内衬。提供了技术描述和当前结果的综述。仅发表了4个系列超过10例杂交手术的病例。此类手术的经验表明其具有可行性,但大多数报告描述其死亡率持续居高不下(高达25%)。已发表了更大系列的开窗型支架型人工血管治疗肾周动脉瘤的病例,中期结果证实了该手术的安全性和有效性。一项更大规模的多中心试验正在进行中。其他单纯的血管内方法已用于治疗胸腹主动脉瘤,包括强化开窗和定向分支。不算小系列病例(<10例),有2个系列约100例病例,其围手术期死亡率在3%至6%之间,且无晚期破裂的证据。
胸腹主动脉瘤的血管内修复是可行的,且围手术期死亡率相对较低。已描述了几种将内脏血管纳入的方法。由于死亡率持续居高不下,杂交手术可能会留给患有较大动脉瘤的非手术和非血管内治疗患者。带分支的血管内移植物在不断发展,并将在临床试验中进行评估。